Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past.

Name: Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past.
Published: 2002
License: Public Domain

Bristol-Myers Squibb · 2002

ClinicalTrials.gov · Datasets · License: Public Domain · 2002

Open Source ↗

rheumatoid-arthritis

rheumatoid arthritis, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past.

Related documents